SNY
1:00 AM
News Updates
Thu, May 28, 2026
1 updatesMon, May 18, 2026
1 updatesSNY
3:47 PM
ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
Presentation / Abstract • Phase 2ATS presentation Mon, May 18, 2026sanofi.com
Tue, May 5, 2026
1 updatesSNY
7:00 AM
DDW: Sanofi and Regeneron’s DUPIXENT® demonstrates improved esophageal function in eosinophilic esophagitis phase 4 study
Presentation / Abstract • Phase 4sanofi.com
Wed, Apr 22, 2026
3 updatesSat, Apr 18, 2026
1 updatesSNY
6:00 AM
ESCMID: Sanofi’s NUVAXOVID™ COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
Trial Results • Phase 4sanofi.com
Sat, Mar 28, 2026
1 updatesSNY
11:00 AM
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Trial Results • Phase 3sanofi.com